TerminatedNot Applicable

Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

Stopped: Obsolete study

France5 participantsStarted 2016-02

Plain-language summary

The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient older than 18 years old * Patient with ECMO * Patient hospitalized in an intensive care unit at the University Hospital of Rennes Exclusion Criteria: * Known history for constitutional pathology of the primary haemostasis * Platelets \< 100000 / mm3 or hematocrit \< 28 % between H+12 and H+24

What they're measuring

Evaluate primary hemostasis in patient with ECMO at University Hospital of Rennes

Timeframe: Day 5

Trial details

NCT IDNCT03248596

SponsorRennes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-07

View on ClinicalTrials.gov More Patients With ECMO trials